Oncology API’s

Oncology API’s

Sr.No. Product Specifications DMF
1Abiraterone acetateUSP / IP
2AnastrozoleUSP / IP / EP
3AzacitidineIH
4BicalutamideUSP / EP
5BortezomibIP / IH
6CapecitabineUSP / IP
7CarboplatinEP / BP / USP / IP
8CisplatinEP / BP / IP
9CladribineUSP
10CytarabineEP / BP / USP / IP
11DacarbazineEP / BP / USP / IP
12Docetaxel trihydrateEP / USP / IP
13Erlotinib HClIP / IH
14EtoposideUSP / EP / BP / IP
15GefitinibEP / IP / IH
16Gemcitabine HClEP / BP / USP / IP
17Imatinib mesylateEP / IP / IH
18Irinotecan HClEP / USP / IP
19LenalidomideIH
20LetrozoleEP / BP / USP
21MethotrexateEP / BP / USP / IP
22Nilotinib HCl monohydrateEP
23OxaliplatinEP / BP / USP
24PaclitaxelEP / USP / IP
25PalbociclibIH
26Pemetrexed disodium heptahydrateEP / USP / IP
27PomalidomideIH
28Sorafenib tosylateIP / IH / EP
29Sunitinib malateIH
30TemozolomideUSP / IP
31TopotecanIP / IH
32Zoledronic acidIP / IH

Note:
Product protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement. All those responsibility of patent applicability shall remain with importer.

Copyright © All rights reserved by Amtec Health Care Private Limited

TOP